Literature DB >> 15060173

Rescue of an hTERT mutant defective in telomere elongation by fusion with hPot1.

Blaine N Armbruster1, Corinne M Linardic, Tim Veldman, Niharika P Bansal, Diane L Downie, Christopher M Counter.   

Abstract

The protein hPot1 shares homology with telomere-binding proteins in lower eukaryotes and associates with single-stranded telomeric DNA in vitro as well as colocalizing with telomere-binding proteins in vivo. We now show that hPot1 is coimmunoprecipitated with telomeric DNA and that stable expression of this protein in telomerase-positive cells results in telomere elongation, supporting the idea that hPot1 is a bona fide mammalian telomere-binding protein. We previously found that mutations in the N-terminal DAT domain of the hTERT catalytic subunit of telomerase rendered the enzyme catalytically active but unable to elongate telomeres in vivo. This phenotype could be partially rescued by fusion with the double-stranded telomeric protein hTRF2. Given that hPot1 binds to single-stranded DNA in vitro (at the same site that hTERT binds to in vivo), we addressed whether fusion of hPot1 can rescue the DAT mutations more efficiently than that of hTRF2. We now report that a DAT mutant of hTERT is indeed efficiently rescued upon fusion to hPot1. However, this rescue depended on the ability of hPot1 to localize to telomeres rather than binding to DNA per se. These data support a model whereby the DAT domain of hTERT is implicated in telomere-telomerase associations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15060173      PMCID: PMC381596          DOI: 10.1128/MCB.24.8.3552-3561.2004

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  42 in total

Review 1.  Switching and signaling at the telomere.

Authors:  E H Blackburn
Journal:  Cell       Date:  2001-09-21       Impact factor: 41.582

2.  Pot1, the putative telomere end-binding protein in fission yeast and humans.

Authors:  P Baumann; T R Cech
Journal:  Science       Date:  2001-05-11       Impact factor: 47.728

3.  Functional multimerization of human telomerase requires an RNA interaction domain in the N terminus of the catalytic subunit.

Authors:  Tara J Moriarty; Sylvain Huard; Sophie Dupuis; Chantal Autexier
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

4.  Cdc13 delivers separate complexes to the telomere for end protection and replication.

Authors:  E Pennock; K Buckley; V Lundblad
Journal:  Cell       Date:  2001-02-09       Impact factor: 41.582

5.  Ten1 functions in telomere end protection and length regulation in association with Stn1 and Cdc13.

Authors:  N Grandin; C Damon; M Charbonneau
Journal:  EMBO J       Date:  2001-03-01       Impact factor: 11.598

6.  Est1 and Cdc13 as comediators of telomerase access.

Authors:  S K Evans; V Lundblad
Journal:  Science       Date:  1999-10-01       Impact factor: 47.728

7.  Functional multimerization of the human telomerase reverse transcriptase.

Authors:  T L Beattie; W Zhou; M O Robinson; L Harrington
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

8.  Synergistic coupling of histone H3 phosphorylation and acetylation in response to epidermal growth factor stimulation.

Authors:  P Cheung; K G Tanner; W L Cheung; P Sassone-Corsi; J M Denu; C D Allis
Journal:  Mol Cell       Date:  2000-06       Impact factor: 17.970

Review 9.  Protection of mammalian telomeres.

Authors:  Titia de Lange
Journal:  Oncogene       Date:  2002-01-21       Impact factor: 9.867

10.  N-terminal domains of the human telomerase catalytic subunit required for enzyme activity in vivo.

Authors:  B N Armbruster; S S Banik; C Guo; A C Smith; C M Counter
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

View more
  39 in total

1.  Telomerase recruitment requires both TCAB1 and Cajal bodies independently.

Authors:  J Lewis Stern; Katherine G Zyner; Hilda A Pickett; Scott B Cohen; Tracy M Bryan
Journal:  Mol Cell Biol       Date:  2012-04-30       Impact factor: 4.272

2.  ATM and ATR Signaling Regulate the Recruitment of Human Telomerase to Telomeres.

Authors:  Adrian S Tong; J Lewis Stern; Agnel Sfeir; Melissa Kartawinata; Titia de Lange; Xu-Dong Zhu; Tracy M Bryan
Journal:  Cell Rep       Date:  2015-11-12       Impact factor: 9.423

3.  Alterations of DNA and chromatin structures at telomeres and genetic instability in mouse cells defective in DNA polymerase alpha.

Authors:  Mirai Nakamura; Akira Nabetani; Takeshi Mizuno; Fumio Hanaoka; Fuyuki Ishikawa
Journal:  Mol Cell Biol       Date:  2005-12       Impact factor: 4.272

4.  Distinct requirements for Pot1 in limiting telomere length and maintaining chromosome stability.

Authors:  Jeremy T Bunch; Nancy S Bae; Jessica Leonardi; Peter Baumann
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

Review 5.  Telomere length homeostasis.

Authors:  Nele Hug; Joachim Lingner
Journal:  Chromosoma       Date:  2006-06-02       Impact factor: 4.316

Review 6.  Chromosome end maintenance by telomerase.

Authors:  Jennifer L Osterhage; Katherine L Friedman
Journal:  J Biol Chem       Date:  2009-03-12       Impact factor: 5.157

7.  Function, replication and structure of the mammalian telomere.

Authors:  Dominique Broccoli
Journal:  Cytotechnology       Date:  2004-06       Impact factor: 2.058

8.  A small molecule inhibitor of Pot1 binding to telomeric DNA.

Authors:  Sarah E Altschuler; Johnny E Croy; Deborah S Wuttke
Journal:  Biochemistry       Date:  2012-09-26       Impact factor: 3.162

9.  The Arabidopsis Pot1 and Pot2 proteins function in telomere length homeostasis and chromosome end protection.

Authors:  Eugene V Shakirov; Yulia V Surovtseva; Nathan Osbun; Dorothy E Shippen
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

10.  Expression of (NES-)hTERT in cancer cells delays cell cycle progression and increases sensitivity to genotoxic stress.

Authors:  Olga A Kovalenko; Jessica Kaplunov; Utz Herbig; Sonia Detoledo; Edouard I Azzam; Janine H Santos
Journal:  PLoS One       Date:  2010-05-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.